Sphera Funds Management »

Ovid Therapeutics shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6M 1.6M 2.22
2017-12-31 $1.8M 181k 9.87
2017-09-30 $2.6M 306k 8.57
2017-06-30 $3.0M 306k 9.95

More positions owned by Sphera Funds Management

Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Tower Semiconductor Shs New (TSEM)
Spdr Series Trust State Street Spd Put Option (XBI)
NOVA MEASURING Instruments L (NVMI)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Biogen Idec (BIIB)
Ultragenyx Pharmaceutical (RARE)
Syndax Pharmaceuticals (SNDX)
Cogent Biosciences (COGT)
Sanofi Sa Sponsored Adr (SNY)
Astrazeneca Ord (AZN)
Amicus Therapeutics (FOLD)
Cellebrite Di Ordinary Shares (CLBT)

View all positions for Sphera Funds Management

Top funds holding Ovid Therapeutics

RA Capital Management
Henderson Group
Affinity Asset Advisors
Balyasny Asset Management
Vanguard Capital Management
ADAR1 Capital Management
Eventide Asset Management
Federated Investors
Adage Capital Partners GP
Vanguard Group
Ikarian Capital
Ally Bridge Group
Saturn V Capital Management
Sphera Funds Management
BlackRock

View all funds holding Ovid Therapeutics